EI
ALXN

Ellevest Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Ellevest Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,945
Closed -$357K – 1677
2021
Q2 		$357K Buy
1,945
+118
+6% +$20.3K 0.04% 128
2021
Q1 		$279K Buy
1,827
+556
+44% +$86K 0.03% 145
2020
Q4 		$199K Buy
1,271
+934
+277% +$120K 0.03% 169
2020
Q3 		$39K Buy
337
+210
+165% +$22.7K 0.01% 419
2020
Q2 		$14K Buy
127
+14
+12% +$1.49K ﹤0.01% 560
2020
Q1 		$10K Buy
113
+3
+3% +$294 ﹤0.01% 559
2019
Q4 		$12K Buy
110
+101
+1,122% +$10.8K ﹤0.01% 512
2019
Q3 		$1K Buy
+9
New +$1.01K ﹤0.01% 485

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return